HIGHLIGHTS
- who: Rosario Pivonello from the Frontiers Media SA, SwitzerlandNetherlands, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Miami, Miami, FL have published the Article: Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study, in the Journal: (JOURNAL) of 18/03/2022
SUMMARY
A Corrigendum on Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study By Pivonello R, Bancos I, Feelders RA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.